NEW YORK (GenomeWeb News) – Agilent said today that it has signed a co-marketing agreement with Picometrics Technologies to provide combined solutions for capillary electrophoresis, laser induced fluorescence detection, and mass spectrometry for biopharmaceutical applications.
The platform is intended for the research and development of complex large-molecule biopharmaceutical compounds, and is the only online CE-LIF-MS solution currently available, Agilent said.
"This unique technological platform using our new-generation LIF detection will significantly increase efficiency for biotherapeutic characterization in research, development and quality control," Jean Charles Garcia, president of Picometrics, said in a statement.
"We are excited to collaborate with Picometrics and provide this unique product offering to the biopharmaceutical industry — particularly those focusing on the research and development of NBEs, or new biological entities," said Michael Frank, Agilent marketing director, liquid phase separations.
Financial and other details of the agreement were not disclosed.